A detailed history of Phocas Financial Corp. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Phocas Financial Corp. holds 63,997 shares of ACAD stock, worth $946,515. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63,997
Previous 65,207 1.86%
Holding current value
$946,515
Previous $1.21 Million 13.76%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$14.62 - $18.42 $17,690 - $22,288
-1,210 Reduced 1.86%
63,997 $1.04 Million
Q1 2024

Apr 30, 2024

SELL
$17.79 - $30.86 $31,132 - $54,005
-1,750 Reduced 2.61%
65,207 $1.21 Million
Q4 2023

Jan 29, 2024

BUY
$20.78 - $31.77 $26,307 - $40,220
1,266 Added 1.93%
66,957 $2.1 Million
Q3 2023

Oct 10, 2023

BUY
$20.84 - $33.47 $1.37 Million - $2.2 Million
65,691 New
65,691 $1.37 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Phocas Financial Corp. Portfolio

Follow Phocas Financial Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

News

Stay updated on Phocas Financial Corp. with notifications on news.